These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35691207)

  • 21. Driving Impairment Cases Involving Flualprazolam.
    Youso KB; Osawa KA; Divine ML; Rohrig TP
    J Anal Toxicol; 2022 Aug; 46(7):e191-e195. PubMed ID: 35404449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent findings and advancements in the detection of designer benzodiazepines: a brief review.
    Wu D; Fu L
    Arh Hig Rada Toksikol; 2022; 74(4):224-231. PubMed ID: 38146763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of new exemestane metabolites by liquid chromatography interfaced to electrospray-tandem mass spectrometry.
    de Albuquerque Cavalcanti G; Carius Garrido B; Dias Leal F; Costa Padilha M; Mazzarino M; de la Torre X; Botre F; Radler de Aquino Neto F
    J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):248-54. PubMed ID: 21924357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase I metabolism of the highly potent synthetic cannabinoid MDMB-CHMICA and detection in human urine samples.
    Franz F; Angerer V; Moosmann B; Auwärter V
    Drug Test Anal; 2017 May; 9(5):744-753. PubMed ID: 27504870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Femoral blood concentrations of flualprazolam in 33 postmortem cases.
    Kriikku P; Rasanen I; Ojanperä I; Thelander G; Kronstrand R; Vikingsson S
    Forensic Sci Int; 2020 Feb; 307():110101. PubMed ID: 31865266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LC-(TOF) MS analysis of benzodiazepines in urine from alleged victims of drug-facilitated sexual assault.
    ElSohly MA; Gul W; Murphy TP; Avula B; Khan IA
    J Anal Toxicol; 2007 Oct; 31(8):505-14. PubMed ID: 17988465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Identification of New Psychoactive Tryptamines 4-OH-MET and 4-AcO-DMT Using High Resolution Mass Spectrometry and Nuclear Magnetic Resonance Spectroscopy].
    Ding KR; Ni CF; He SY; Wang KD; Deng QY; Liang C
    Fa Yi Xue Za Zhi; 2021 Aug; 37(4):511-515. PubMed ID: 34726004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of an LC-MS/MS Method for the Quantification of 13 Designer Benzodiazepines in Blood.
    Mei V; Concheiro M; Pardi J; Cooper G
    J Anal Toxicol; 2019 Oct; 43(9):688-695. PubMed ID: 31436813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human urinary metabolic patterns of the designer benzodiazepines flubromazolam and pyrazolam studied by liquid chromatography-high resolution mass spectrometry.
    Pettersson Bergstrand M; Meyer MR; Beck O; Helander A
    Drug Test Anal; 2018 Mar; 10(3):496-506. PubMed ID: 28677876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
    Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
    J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative analysis of 33 benzodiazepines, metabolites and benzodiazepine-like substances in whole blood by liquid chromatography-(tandem) mass spectrometry.
    Smink BE; Brandsma JE; Dijkhuizen A; Lusthof KJ; de Gier JJ; Egberts AC; Uges DR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Nov; 811(1):13-20. PubMed ID: 15458716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of seized peptide and protein-based doping agents using four complimentary methods: Liquid chromatography coupled with time of flight mass spectrometry, liquid chromatography-ultraviolet, Bradford, and immunoassays.
    Høj LJ; Rasmussen BS; Dalsgaard PW; Linnet K
    Drug Test Anal; 2021 Jul; 13(7):1457-1463. PubMed ID: 33686802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative determination and metabolic profiling of synthetic cathinone eutylone in vitro and in urine samples by liquid chromatography tandem quadrupole time-of-flight mass spectrometry.
    Yeh YL; Wang SM
    Drug Test Anal; 2022 Jul; 14(7):1325-1337. PubMed ID: 35332690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and Validation of an LC-MS-MS Method for the Detection of 40 Benzodiazepines and Three Z-Drugs in Blood and Urine by Solid-Phase Extraction.
    Sofalvi S; Lavins ES; Kaspar CK; Michel HM; Mitchell-Mata CL; Huestis MA; Apollonio LG
    J Anal Toxicol; 2020 Oct; 44(7):708-717. PubMed ID: 32808043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of LC-TOF-MS screening for drugs, metabolites, and collateral compounds in forensic toxicology specimens.
    Guale F; Shahreza S; Walterscheid JP; Chen HH; Arndt C; Kelly AT; Mozayani A
    J Anal Toxicol; 2013; 37(1):17-24. PubMed ID: 23118149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urine toxicology screening by liquid chromatography time-of-flight mass spectrometry in a quaternary hospital setting.
    Pope JD; Black MJ; Drummer OH; Schneider HG
    Clin Biochem; 2021 Sep; 95():66-72. PubMed ID: 33989561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitive Screening of New Psychoactive Substances in Serum Using Liquid Chromatography-Quadrupole Time-of-Flight Mass Spectrometry.
    Kleis JN; Hess C; Germerott T; Roehrich J
    J Anal Toxicol; 2022 Jul; 46(6):592-599. PubMed ID: 34125215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of simultaneous gas chromatography-mass spectrometric and liquid chromatography-electrospray ionization mass spectrometric determination method for the new designer drugs, N-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl)piperazine (TFMPP) and their main metabolites in urine.
    Tsutsumi H; Katagi M; Miki A; Shima N; Kamata T; Nishikawa M; Nakajima K; Tsuchihashi H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(2):315-22. PubMed ID: 15833296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comprehensive analytical process, from NPS threat identification to systematic screening: Method validation and one-year prevalence study.
    Garneau B; Desharnais B; Laquerre J; Côté C; Taillon MP; Martin PY; Daigneault G; Mireault P; Lajeunesse A
    Forensic Sci Int; 2021 Jan; 318():110595. PubMed ID: 33279767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Fatal Case Report Resulting from the Abuse of the Designer Benzodiazepines Clonazolam and Flualprazolam in Conjunction with Dried Opium Poppy Pods‡.
    Theofel N; Möller P; Vejmelka E; Kramer C; Tsokos M; Scholtis S
    J Anal Toxicol; 2023 Jan; 46(9):e285-e290. PubMed ID: 36516236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.